Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2017

Aug 29, 2017

30237_dirs_2017-08-29_be6a1653-495e-4f7b-b318-cacb003982bc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2017-08-25

Reporting Person: EBERTS F SAMUEL III (Chief Legal Officer, Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-25 Common Stock M 8200 $60.04 Acquired 31894 Direct
2017-08-25 Common Stock M 14100 $70.15 Acquired 45994 Direct
2017-08-25 Common Stock M 9200 $75.63 Acquired 55194 Direct
2017-08-25 Common Stock S 31500 $155.2213 Disposed 23694 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-08-25 Non-qualified Stock Options $60.04 M 8200 Disposed 2019-02-11 Common Stock (8200) Direct
2017-08-25 Non-qualified Stock Options $70.15 M 14100 Disposed 2020-02-09 Common Stock (14100) Direct
2017-08-25 Non-qualified Stock Options $75.63 M 9200 Disposed 2018-05-07 Common Stock (9200) Direct

Footnotes

F1: The price of $155.2213 per share represents a weighted average of sales prices ranging from $155.01 to $155.62 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F2: Employee stock option (right to buy) granted persuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.

F3: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.